A combination of two potential drugs gives hope of a ‘super blockage’ of an over-active immune system, Leiden researchers report in Nature. The breakthrough came from the crystallisation of a membrane protein.
Over-alert immune system
Our immune system is intended to protect the body against infiltrators. But sometimes it behaves too alertly, attacking the body itself. This results in chronic inflammation, such as multiple sclerosis, rheumatism or osteoarthritis.
Inhibiting inflammatory reactions
Laura Heitman, Ad IJzerman, Henk de Vries and Natalia Ortiz Zacarias from the Leiden Academic Centre for Drug Research (LACDR) are publishing their research this week in the journal Nature, research that may lead to a more effective way of inhibiting these responses. Their research focuses on the CCR2 receptor. The Leiden researchers work closely with an American team headed by Tracy Handel and Irina Kufureva.
Keyhole at nanoscale
A receptor is a kind of keyhole at nanoscale on the outside of a cell – in the cell membrane – into which a specific key molecule fits. The immune system comprises all kinds of immune cells, each with different types of receptors. The key molecules are called chemokines, and are produced by cells in diseased tissue. Immune cells are attracted automatically towards higher concentrations of chemokine, which generally means towards parts of the body where they are needed.
Inhibitors ineffective
But patients with rheumatism or osteoarthritis produce too much CCL2, the chemokine for the CCR2 receptor. Although there are ways of blocking the CCR2 receptor, which in turn inhibits the inflammation, the inhibitors currently available prove to be largely ineffective in humans.
Protein crystallisation
In order to discover how this process works at atomic level, Heitman and her colleagues examined the CCR2 protein using X-rays. This cannot be done using whole cells or a fragment of the cell membrane, where other proteins are also present. The researchers needed to have the CCR2 protein in very pure crystal form. This had never previously been done successfully. Laura Heitman: ‘If you take this kind of protein from the cell membrane, it’s very difficult to crystallise it.’
Thanks to this advance, researchers now have a detailed understanding of the three-dimensional form of the CCR2 protein, which is a good starting point for further research on the interaction beteween CCR2 and the related CCL2 chemokine.The research had immediate results: crystallisation was only possible if two inhibitors (BMS-681 and CCR2-RA-[R]) are both added to the CCR2 protein.
Possible duo medicine
Heitman: ‘This suggests a new strategy: duo therapy. By administering these two substances at the same time, you get a kind of “super blockage” of the CCR2 receptor, which is more effective than administering the two substances separately.’ Heitman refers to these substances deliberately as ‘potential medicines’: this is just the start of a process that could lead to a new duo medicine.
Other receptors
Heitman’s group will first continue their work with other receptors, CCR1 and CCR3 up to and including CCR9 before considering other super inhibitors. The ultimate aim is to manipulate the immune system so effectively that it only has beneficial effects, and the detrimental effects are excluded.
Learn more: Two-pronged attack on infectious diseases
[osd_subscribe categories=’immune-system-2′ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “IMMUNE SYSTEM”‘]
Receive an email update when we add a new IMMUNE SYSTEM article.
The Latest on: Overactive immune system
[google_news title=”” keyword=”overactive immune system” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Overactive immune system
- COVID Rash: Explaining Short- and Long-Term Symptomson April 30, 2024 at 6:43 am
A rash from COVID-19 may or may not itch. They occur in places all over the body. Learn about the link between long COVID and rash.
- The Human Immunome Project unveils scientific plan to decode and model the immune systemon April 29, 2024 at 6:30 am
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
- Study rethinks immune system strategies to boost vaccine effectivenesson April 28, 2024 at 9:52 pm
A recent Cell journal review explores key immunological assumptions to enhance our understanding of vaccine design, autoimmune responses, and immune system pathology, aiming to refine intervention ...
- Reprogramming the immune system to attack cancer cellson April 22, 2024 at 11:31 am
Researchers at Virginia Tech's developed a new therapy to target cancer with localized cytokine treatment to boost the immune system.
- Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?on April 22, 2024 at 5:51 am
Inflammation is one of the underlying causes of psoriasis, and research shows that an anti-inflammatory diet can help prevent flare-ups. Here's what you need to know.
- Immunotherapy Developed To Localize Cancer-Killing Moleculeson April 21, 2024 at 5:00 pm
Immunotherapy involves harnessing the power of the body’s immune system to fight against cancer cells ... they’ll activate every immune cell they encounter, which can cause an overactive immune ...
- Cancer Breakthrough Found to Boost Immune Cells Without Harmful Side-Effects By Directing Protein Cytokineson April 21, 2024 at 7:00 am
A new way to safely boost immune cells to fight cancer—avoiding harmful side-effects such as hair loss—has been developed.
- Researchers develop new method to boost immune cells for fighting canceron April 20, 2024 at 9:23 am
“The whole class of drugs that are employed to jump-start the immune system to fight cancer cells has largely not yet succeeded. Our goal is to create novel solutions that allow researchers to test ...
- Researchers develop a new way to safely boost immune cells to fight canceron April 19, 2024 at 11:01 am
Last year alone, more than 600,000 people in the United States died from cancer, according to the American Cancer Society. The relentless pursuit of understanding this complex disease has shaped ...
via Bing News